November 2019, Wounds UK, Harrogate, UK Two symposia at the Wounds UK conference in Harrogate in November 2019, outlined how Accel-Heal®, a single use, portable, easy-to-use electrical stimulation device can improve clinical practice. Dr Leanne Atkin opened the proceedings describing that the evidence is clear that compression therapy improves the healing of venous leg...
Accel-Heal are delighted to announce the establishment of a Clinical and Scientific Advisory Board comprised of eminent experts in the fields of Wound Healing research, science, clinical practice, pain management and health economics. The Board is chaired by Dr Robin Martin, PhD, Independent Scientific Consultant and is joined by the following members: Dr Leanne...
The use of innovative technologies for transforming and improving clinical outcomes and reducing costs in the NHS was an integral component of the NHS Five Year Forward View (2014). The use of electroceutical treatment has been demonstrated to both improve patient outcomes and reduce costs to the NHS for the management of chronic wounds. Read...
It is estimated that the annual prevalence of chronic wounds is growing at the rate of 12%; largely as a result of an average healing rate of 43%. At this growth rate, chronic wounds alone (leg, foot and pressure ulcers) are expected to cost £5.3bn per annum by 2017/2018 and £9.4bn a year in another...
Of the £5.3 billion the NHS spend every year treating wounds, over £3.0 billion a year is spent on managing chronic wounds (leg ulcers, diabetic foot ulcers and pressure sores) alone. The majority (74%) of this spend was on wounds that did not heal in the year. Healed wounds cost £800 million while unhealed wounds...
Use of electroceutical treatment effectively restores the current of injury, expediting normal healing and reducing chronic inflammation, biofilms, infection and associated symptoms, such as pain and high exudate. Clinical outcomes and QoL are improved and there are also economic benefits. Read the publication here: Using electroceutical treatment to reduce symptoms and improve healing in chronic...
Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer, Bucks New University delivered a presentation on the clinical and cost-effectiveness of Accel-Heal® on hard-to-heal wounds. View the poster here: Breaking the cycle of hard-to-heal wounds with electroceutical treatment (pdf) Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer Bucks New University, Wounds UK Bristol Nurse Symposium,...
Cost-effective management and healing of VLUs remains a challenging problem for the NHS. The study found that the annual cost of managing an unhealed VLU was £13,500 compared to £3,000 for a healed VLU based on 2015/2016 prices. The number of new VLUs in the UK has been estimated to rise to 170 000 in...